⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30296951 | 1.00 | — | — | |
| Iodide SCHEMBL31555020 | 0.97 | — | — | |
| Iodide SCHEMBL25383872 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL31169153 | 0.97 | — | — | |
| SCHEMBL20813392 | 0.74 | MIF (0.52) | — | |
| SCHEMBL2814353 | 0.69 | HSP90AA1 (0.52) | — | |
| SCHEMBL30595872 | 0.69 | HSP90AA1 (0.52) | — | |
| SCHEMBL26376426 | 0.67 | — | — | |
| SCHEMBL13910999 | 0.67 | HSP90AA1 (0.50) | — | |
| SCHEMBL1061567 | 0.66 | CYP2D6 (0.51) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 460 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3131914-B1 | 3'-SUBSTITUTED METHYL OR ALKYNYL NUCLEOSIDES FOR THE TREATMENT OF HCV | IDENIX PHARMACEUTICALS LLC (US) | 2023-05-10 | — | — | EP | claimed |
| EP-4714452-A1 | METHODS FOR TREATING SARS COV-2 INFECTIONS | Gilead Sciences, Inc. (US) | 2026-03-25 | — | — | EP | disclosed |
| US-12509466-B2 | Methods and compounds for treating paramyxoviridae virus infections | GILEAD SCIENCES, INC. (US) | 2025-12-30 | — | — | US | disclosed |
| US-20250388536-A1 | 3-ALKYNYL CARBOXAMIDES AS AEP MODULATORS | HOFFMANN-LA ROCHE INC. (US) | 2025-12-25 | — | — | US | disclosed |
| EP-4651871-A2 | ECTEINASCIDIN DERIVATIVE ANTIBODY DRUG CONJUGATES | Adcytherix SAS (FR) | 2025-11-26 | — | — | EP | disclosed |
| EP-4605396-A1 | ANTICORONVIRAL COMPOUNDS AND COMPOSITIONS AND USES THEREOF | Shanghai Curegene Pharmaceutical Co., Ltd. (CN) | 2025-08-27 | — | — | EP | disclosed |
| EP-4591935-A2 | METHODS FOR THE PREPARATION OF RIBOSIDES | Gilead Sciences, Inc. (US) | 2025-07-30 | — | — | EP | disclosed |
| EP-4588928-A2 | METHODS FOR TREATING FILOVIRIDAE VIRUS INFECTIONS | Gilead Sciences, Inc. (US) | 2025-07-23 | — | — | EP | disclosed |
| WO-2025119207-A1 | ANTIVIRAL COMPOUNDS AND COMPOSITIONS AND USES THEREOF | SHANGHAI CUREGENE PHARMACEUTICAL CO., LTD. (CN) | 2025-06-12 | — | — | WO | disclosed |
| EP-4036099-B1 | METHODS FOR THE PREPARATION OF RIBOSIDES | GILEAD SCIENCES INC (US) | 2025-03-19 | — | — | EP | disclosed |
| US-7456155-B2 | 2′-C-methyl-3′-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections | IDENIX PHARMACEUTICALS, INC. (US) | 2008-11-25 | — | — | US | disclosed |
| WO-2008087057-A1 | PREPARATION AND USE OF MAGNESIUM AMIDES | LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN (DE) | 2008-07-24 | — | — | WO | disclosed |
| CN-101172993-A | 2'-c-methyl-3'-o-l-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections | CENTRE NAT RECH SCIENT (KY) | 2008-05-07 | — | — | CN | disclosed |
| US-20070275883-A1 | 2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections | IDENIX PHARMACEUTICALS, INC. | 2007-11-29 | — | — | US | disclosed |
| EP-1536804-A4 | 2'-C-METHYL-3'-O-L-VALINE ESTER RIBOFURANOSYL CYTIDINE FOR TREATMENT OF FLAVIVIRIDAE INFECTIONS | IDENIX CAYMAN LTD (KY) | 2007-10-31 | — | — | EP | disclosed |
| CN-1823072-A | Inhibitors of P38 and methods of using the same | ARQULE INC (US) | 2006-08-23 | — | — | CN | disclosed |
| CN-1678326-A | 2 '-C-methyl-3' -O-L-valine ester ribofuranosyl cytidine for treatment of flavivirus infections | IDENIX CAYMAN LTD (KY) | 2005-10-05 | — | — | CN | disclosed |
| EP-1536804-A2 | 2'-C-METHYL-3'-O-L-VALINE ESTER RIBOFURANOSYL CYTIDINE FOR TREATMENT OF FLAVIVIRIDAE INFECTIONS | Idenix (Cayman) Limited (KY) | 2005-06-08 | — | — | EP | disclosed |
| US-20040077587-A1 | 2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections | IDENIX PHARMACEUTICALS, INC. | 2004-04-22 | — | — | US | disclosed |
| WO-2004002422-A2 | 2’-C-METHYL-3’-O-L-VALINE ESTER RIBOFURANOSYL CYTIDINE FOR TREATMENT OF FLAVIVIRIDAE INFECTIONS | IDENIX (CAYMAN) LIMITED (KY) | 2004-01-08 | — | — | WO | disclosed |